Materials and Methods
Mice. The strains used in these studies are listed in Table I , which indicates their MHC types and Igh types. They were obtained from the Small Animal Section, Division of Research Services, National Institutes of Health (NIH) (Bethesda, Md.) or The Jackson Laboratory (Bar Harbor, Maine), or were the kind gift of Dr. Michael Potter, NIH. F1 hybrids were bred in the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, NIH.
Antigens. BL (2 × 107 daltons), from
Aerobacter levanicum (ATCC 1,552), was obtained as previously described (6) . In coupled to Brucella abortus (In-BA) and In coupled to keyhole limpet hemocyanin (KLH) (In-KLH) were prepared as described by Chien et al. (7) .
Immunization of Mice. Adult mice (8-12 wk of age) were immunized intravenously with 10-50/tg of BL in saline and were bled 5, 10, 20, 40, and 60 d after immunization. Other mice were immunized with 0.1 ml of a 1% suspension of In-BA, emulsified in complete Freund's adjuvant (CFA) (Difco Laboratories, Detroit, Mich.), and bled 10 d later. Mice immunized with In-KLH or KLH were given 100 /~g of antigen in CFA, intraperitoneally, and were boosted at 2 and 3 wk with 50/lg of antigen in incomplete Freund's adjuvant. They were bled 1 wk after the last injection.
Determination of Immunoglobulin Allotypes. Allotype analysis was performed as described by Lieberman (8) .
Determination of H-2 Types. H-2 typing was performed by a modification of the microcytotoxicity method described by Sachs et al. (9) . Typing was performed on peripheral blood lymphocytes isolated by Ficoll (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.)-Hypaque (Winthrop Laboratories, New York) centrifugation (D. Sachs. Personal communication.) with anti-H-2 d and H-2 b sera provided by Dr. David Sachs, National Cancer Institute, NIH.
IEF. IEF was performed by a modification of the method described by Briles and Davie (10) and refined by Nicolotti et al. (11) . 3-Methacryloxypropyltrimethoxysilane (methacrylsilane) and N,N'-diallyltartardiamide (DATD) were purchased from Polysciences, Inc., Warrington, Pa. Acrylamide, N,N'-methylene-bis-acrylamide (Bis), and N,N,N',N'-tetramethylethylenediamine (TEMED) were purchased from Bio-Rad Laboratories, Richmond, Calif. Riboflavin, taurine, and lysine (free base) were purchased from Sigma Chemical Co., St. Louis, Mo., and ampholines were purchased from LKB Instruments, Inc., Rockville, Md. Ultrapure urea was purchased from BRL, Inc., Rockville, Md., and stock solutions were deionized on a mixed-bed ion-exchange resin column of Amberlite, MB-3 (Mallinckrodt Inc., St. Louis, Mo.). Glutaraldehyde was purchased from Eastman Kodak Co., Rochester, N. Y.
A 10-× 15-cm gel (0.6-ram thick) was cast in a vertical apparatus (10) between a plexiglass backing plate and a glass plate that had been previously treated with methacrylsilane (11) to produce covalent attachment of the acrylamide gel to the glass surface. The gel solution was prepared from the following components: 5.1 ml DATD-acrylamide (3% [wt/vol] DATD + 17% [wt/vol] acrylamide); 7.75 ml 8 M urea; 5.1 g glycerol; 0.7 ml pH 5-8 ampholines; 0.4 ml pH 8-9.5 ampholines (the mixture was degassed for 1-2 min before adding catalysts); 1 ml riboflavin (4 mg/100 ml); 100 ~1 TEMED (20%); and 100/~1 ammonium persulfate (1%). The gel mixture was immediately poured into a 20-ml syringe and was applied between the plates of the apparatus with a 22-g (1.5-in.) needle. A 2-× 15-cm Bis gel overlay, into which a Teflon (E. I. DuPont de Nemours & Co., Inc., Wilmington, Del.) comb that contained 20 sample slots was imbedded during polymerization, was immediately applied over the DATD-acrylamide mixture with a 3-ml syringe that was fitted with a 22-g needle. The Bis gel was prepared from the following mixture: 1.2 ml 8 M urea; 0.49 ml Bis (33% acrylamide [wt/vol] + 0.81% Bis [wt/ vol]); 1.05 ml H20; 0.16 p~l pH 5-8 ampholines (the mixture was degassed for 30 s before adding the catalysts); 156 #1 riboflavin (4 mg/100 ml); 15.6 #1 TEMED (20%); and 1 ~1 ammonium persulfate. The gels were polymerized for 3 h at room temperature under fluorescent illumination. The Teflon comb was removed from the gel and any unpolymerized gel was aspirated from the sample slots. Serum (10/~1) was mixed with 10 #1 8 M urea and loaded into the sample slots. Samples were then overlaid with ~5 #1 1 M urea that contained 3% pH 3.5-5 ampholines. Gels were run at 2 mA at constant current for 14-15 h at 4°C. The positive electrode compartment (top) was filled with 0.1 M taurine, which contained five drops of phosphoric acid per liter, and the negative electrode compartment (bottom) was filled with 0.1 M lysine (fg'ee base), which contained 2 ml of ethanolamine per liter. After completion of IEF, the gels were rinsed briefly under running distilled water, and the pH was measured over the entire length of the gel with a flat-bed electrode. Immunoglobulins were precipitated by three changes of 18% Na2SO4 over a period of 6 h. The gels were overlaid for 24 h with 15-20 × 106 cpm/gel (or 7-10 × 106 cpm/half gel) of 125I-labeled antigen that was diluted in 18% Na2SO4 that contained 1% bovine serum albumin (BSA). After exposure to labeled antigen, the gels were washed for 24 h with at least three changes of 18% Na2SO4 and were fixed for 30 min in 18% Na2SO4 that contained 0.5% glutaraldehyde. After fixation, the gels were washed overnight in phosphate-buffered saline (0.02 M PO4 and 0.15 M NaCI, pH 7.4), followed by 6 h in distilled water (three changes), and finally for 1 h in 40% ethanol. The gels were then dried (either overnight in air or for 30 min at 100°C) and exposed to x-ray film. Either Kodak single emulsion SB-5 or double emulsion XR5 film was used. Films were exposed for 7 d. When XR5 film was used, the emulsion on the side of the film not exposed directly to the gel was removed after development of the film by gently rubbing off the emulsion with gauze soaked in a 5.25% solution of NaCIO (commerical laundry bleach) followed by rinsing under running tap water.
Iodinated Antigens. In-BSA was prepared by the method of Chien et al. (7) and iodinated by the chloramine T method (12) to a 30/~Ci//~g sp act. Levan was tyraminated by the method of Keck (13) and iodinated by the chloramine T method to a 10/~Ci/p.g sp act. Labeled antigens were stored at -20°C and used for 4-6 wk.
Results

IEF Pattern of Antibodies Produced by BALB/c Mice Immunized with BL. BALB/c mice
immunized with BL produce antibodies that react with BL and cross-reacting antibodies that bind In. The anti-In antibodies bear the IdX found on many Inbinding myeloma proteins (4) . These BALB/c anti-In antibodies display a characteristic IEF pattern ( Fig. 1 ) that is essentially identical in all individuals, although 1 of the 18 mice shown in Fig. 1 failed to respond to BL. This pattern consists of a single spectrotype comprised of five bands, of which three predominate, and which focus on IEF gels in the pH 6.3-6.8 range (Fig. 1) . The anti-BL antibodies from the same 18 individuals are shown in the lower half of Fig. 1 . As can be seen, the anti-In antibodies react with BL, although weakly, probably a result of the paucity of fl-(2 ~ 1) determinants in BL. Most individuals produced IgG anti-BL in addition to anti-In, and these antibodies are specific for the fi-(2 ---* 6) levan determinant because they do not cross-react with In. Unlike the IEF pattern of anti-In antibodies, which is shared by all individual BALB/c mice, the anti-BL antibodies of these 18 individuals consist of at least five distinct sets of bands, each of which may be considered to be a spectrotype. Moreover, individual sera exhibit different combinations of these spectrotypes. T h e levan-specific antibodies focus between p H 7 a n d 8.5 a n d are thus quite distinct from the anti-In antibodies. Neither the a n t i -I n nor the anti-BL spectrotypes change over a period of 40 d after i m m u n i z a t i o n (Fig. 2) .
To investigate whether the a n t i -I n spectrotype represented the entire clonal repertoire of IgG anti-In antibodies of B A L B / c mice, other B A L B / c mice were i m m u n i z e d with In coupled to various carriers such as K L H a n d B. abortus. I m m u n i z a t i o n s with In-BA a n d I n -K L H were performed in CFA. T h e IEF pattern of anti-In antibodies elicited by In-BA is considerably more heterogeneous than that elicited by BL (Fig. FIG. 2 . IEF pattern of BALB/c anti-BL antibodies at various times after immunization. Sera obtained from two representative individual BALB/c mice at 5, 10, 20, and 40 d after immunization with BL were focused in duplicate in the same gel. The gel was cut and one-half was exposed to ~5I-In-BSA (left panel) and the other to 125I-BL (right panel).
3). The IEF pattern of antibodies elicited by I n -K L H shows even greater complexity (Fig. 3) . We conclude from these data that B A L B / c mice possess an extensive repertoire of anti-In antibodies that, nevertheless, is not fully expressed after immunization with soluble BL.
IEF Pattern of Antibodies Produced by C57BL/6 Mice Immunized with BL. In contrast
to B A L B / c mice, C57BL/6 mice immunized with BL produce high titers of anti-BL antibodies by hemagglutination analysis (HA) but only little or no hemagglutinating anti-In antibodies. They also fail to produce the I d X characteristic of B A L B / c mice (4) . Examination of such antisera by IEF shows that C57BL/6 mice produce IgG anti-BL antibodies but no IgG anti-In antibodies (Fig. 4) . The population of C 5 7 B L / 6 mice expresses two principal anti-BL spectrotypes. An occasional mouse (Fig. 4,  animal 9 ) produces a more complex pattern that appears to consist of the antibodies present in both of the index spectrotypes. The bands seen on the left half of the gel (In overlay) are bands that we consider to represent nonspecific binding because the identical pattern can be seen with sera from unimmunized mice, as well as with immune sera, and with virtually any iodinated antigen that we have examined. No effort has been made to eliminate these bands as they serve as a useful internal marker. (Table II) . Similarly, no linkage of the IEF pattern of anti-In antibodies to the presence of the b M H C haplotype was noted (Table II) . Both patterns were found in both males and females and in mice of the three distinct coat colors found a m o n g the backcross progeny (Table II) . Thus, the C57BL/6 gene that was involved in regulating the Igh a anti-In response appears not to be linked to the Igh complex, to the MHC, or to the genes specifying coat color. As noted earlier (Introduction), we define this gene as Sr-1. T h e equal sex distribution is not informative for X chromosomal linkage of Sr-1 because the (BALB/c X C57BL/6)F1 was the mother of the backcross progeny a n d thus transmitted a C 5 7 B L / 6 X chromosome to one-half of both the male and female offspring. (Fig. 8) , again supporting the conclusion that CXBG mice possess St-1 or another gene that regulates heterogeneity of anti-In antibodies. Similarly, the finding that (CXBI × BALB/c)F1 mice express an anti-In IEF pattern (Fig. 8) that is more complex than that of BALB/c indicates that CXBI, although itself unable to produce anti-In antibodies, possesses an anti-In regulatory gene or genes. Quite surprisingly, the (CXBJ × BALB/c)F1 mice produced anti-In antibodies that were more complex than either parent (Fig. 8) . This suggests that CXBJ does possess a regulatory gene, although it is not expressed in the CXBJ itself.
IEF Pattern of Antibodies Produced by (BALB/c X C57BL/6)F1 and Backcross
IEF Patterns of Antibodies of Rl
Certain of these regulatory effects also appear to be dependent upon homozygosity at the Igh gene complex. Thus, (CXBG × C.B20)F1 mice make an anti-In response to FIG. 6. IEF pattern of B.C8 anti-BL antibodies. Sera obtained from three individual B.C8 mice at various times (as indicated) before or after immunization with BL were focusdd and exposed to a2sI-In-BSA.
BL that resembles that of BALB/c mice rather than that of either CXBG or (CXBG × BALB/c)F1 mice. (CXBG × C.B20)F1 and (CXBG × BALB/c)F1 should differ only in that the former is heterozygous at the Igh gene complex, whereas the latter is homozygous. This effect of Igh gene complex heterozygosity is seen even more strikingly in (CXBJ × C.B20)Fx mice, which fail to produce an IdX-positive anti-In response to BL and lack IgG anti-In antibodies. This failure to produce IgG anti-In antibodies has been observed in analysis of three separate groups of (CXBJ X C.B20)F1 mice immunized on different occasions. To confirm the role of Igh gene complex heterozygosity in the regulation of the anti-In response, (CXBJ X C.B20)F2 mice were bred and immunized with BL. Among 11 mice of this type, 4 were homozygous for the a allotype. Analysis of the anti-In and anti-BL antibodies of eight of these mice by IEF is shown in Fig. 9 . Mice 1, 5, 7, and 11 were found to be homozygous for the a haplotype of the Igh gene complex, whereas mice 2-4 and 10 were found to be a/b heterozygous. One of the a allotype homozygous mice (No. 11) and all of the a/b heterozygous mice produced no or very little IgG anti-In. In contrast, one of the a/a homozygotes (No. 5) produced a weak IgG response characteristic of BALB/c mice, whereas the two others (1 and 7) produced IgG anti-In antibodies substantially more heterogeneous than either CXBJ or BALB/c. This suggests that a heterogeneous anti-In response to BL is favored by the presence of a A second explanation for the observed differences in spectrotype is that C57BL mice contribute a different light chain to the anti-In antibodies than is present in B A L B / c mice and that this results in new clonotype expression. Because there are no markers to distinguish B A L B / c and C57BL light chains, this explanation cannot be directly tested. W e do not favor this explanation, however, because we know that B A L B / c mice can produce heterogeneous anti-In antibodies if they are i m m u n i z e d with stronger immunogens than soluble polysaccharides, such as In-BA or I n -K L H in C F A (Fig. 3) . W e conclude from these studies that B A L B / c mice possess light chains that can participate in the formation of antibodies that express heterogeneous IEF patterns.
A third explanation for the observed regulation is that the increased diversity seen upon introduction of Sr-1 or other C57BL regulatory genes into BALB/c mice results from the expression of additional IgG subclasses and perhaps greater switching from IgM to IgG. Our preliminary data suggest that whereas the IgG anti-In antibodies in BALB/c mice are all of the IgG1 subclass, B.C8 mice produce anti-In antibodies of the IgG2a, IgG2b, and IgG3 subclasses in addition to IgG1. We are currently extending these studies to determine if regulation of Ig class expression is indeed the mechanism through which Sr-1 and other regulatory genes exert their effect and if this is mediated via the T cell. 
